EsoHep - Evaluation of liver function for perioperative risk assessment in patients with esophageal carcinoma

Recruiting

• Conditions: C15.1; C16.0; Thoracic part of oesophagus; Cardia

• Registration Number: DRKS00019201
• Lead Sponsor: niversitätsklinikum Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-12-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

squamous cell carcinoma of the middle or distal esophagus or

adenocarcinoma of the esophagogastric junction Typ I or II with a BMI over 30

neoadjuvant radiochemotherapy or chemotherapy

Initial staging uT2-3 Nx M0

Informed patients consent

Exclusion Criteria

ASA = IV
FEV1 < 1,5 l
ECOG = 2
Non-resectable primary tumours

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Aim is the comparison of the available non-invasive liver function test with the liver biopsy